Novo Nordisk sues two pharmacies for allegedly selling tainted Wegovy, Ozempic knockoffs
Publishing timestamp: 2023-11-30 17:26:15
Summary
Novo Nordisk has sued two compounding pharmacies in Florida for allegedly selling impure and potentially unsafe drugs claiming to contain semaglutide, the active ingredient in their weight loss treatment Wegovy and diabetes medication Ozempic. The Danish drugmaker is facing shortages of these drugs in the U.S. due to high demand. Novo Nordisk is seeking to prevent the pharmacies from selling their products and is raising concerns about the safety risks posed by unknown impurities in the drugs. This is part of a larger legal action by Novo Nordisk against compounding pharmacies selling knockoffs of their drugs.
Sentiment: NEGATIVE
Keywords: health care industry, biotech and pharmaceuticals, novo nordisk a/s, business, eli lilly and co, business news, pharmaceuticals, biotechnology, products and services,
Source: https://www.cnbc.com/2023/11/30/novo-nordisk-sues-pharmacies-over-impure-wegovy-ozempic-dupes.html